Molecular Oncology (Apr 2018)

STAT1 is a sex‐specific tumor suppressor in colitis‐associated colorectal cancer

  • Ilija Crnčec,
  • Madhura Modak,
  • Claire Gordziel,
  • Jasmin Svinka,
  • Irene Scharf,
  • Stefan Moritsch,
  • Paulina Pathria,
  • Michaela Schlederer,
  • Lukas Kenner,
  • Gerald Timelthaler,
  • Mathias Müller,
  • Birgit Strobl,
  • Emilio Casanova,
  • Editha Bayer,
  • Thomas Mohr,
  • Johannes Stöckl,
  • Karlheinz Friedrich,
  • Robert Eferl

DOI
https://doi.org/10.1002/1878-0261.12178
Journal volume & issue
Vol. 12, no. 4
pp. 514 – 528

Abstract

Read online

The interferon‐inducible transcription factor STAT1 is a tumor suppressor in various malignancies. We investigated sex‐specific STAT1 functions in colitis and colitis‐associated colorectal cancer (CRC) using mice with specific STAT1 deletion in intestinal epithelial cells (STAT1∆IEC). Male but not female STAT1∆IEC mice were more resistant to DSS‐induced colitis than sex‐matched STAT1flox/flox controls and displayed reduced intraepithelial infiltration of CD8+ TCRαβ+ granzyme B+ T cells. Moreover, DSS treatment failed to induce expression of T‐cell‐attracting chemokines in intestinal epithelial cells of male but not of female STAT1∆IEC mice. Application of the AOM‐DSS protocol for induction of colitis‐associated CRC resulted in increased intestinal tumor load in male but not in female STAT1∆IEC mice. A sex‐specific stratification of human CRC patients corroborated the data obtained in mice and revealed that reduced tumor cell‐intrinsic nuclear STAT1 protein expression is a poor prognostic factor in men but not in women. These data demonstrate that epithelial STAT1 is a male‐specific tumor suppressor in CRC of mice and humans.

Keywords